36 related articles for article (PubMed ID: 35398618)
1. Nanog suppression enhanced the chemosensitivity of human non-small-cell lung cancer cells to Cisplatin and inhibited cell migration.
Najafzadeh B; Motafakkerazad R; Najafi S; Amini M; Alemohammad H; Vasefifar P; Baradaran B
Pathol Res Pract; 2022 May; 233():153869. PubMed ID: 35398618
[TBL] [Abstract][Full Text] [Related]
2. Targeting Nanog expression increased Cisplatin chemosensitivity and inhibited cell migration in Gastric cancer cells.
Vasefifar P; Najafi S; Motafakkerazad R; Amini M; Safaei S; Najafzadeh B; Alemohammad H; Jafarlou M; Baradaran B
Exp Cell Res; 2023 Aug; 429(2):113681. PubMed ID: 37315760
[TBL] [Abstract][Full Text] [Related]
3. CD44 Suppression Improved the Chemosensitivity of HT-29 Colorectal Cancer Cells to 5-Fluorouracil and Inhibited Cell Migration.
Najafi S; Rahimi Z; Mansoori B; Mohammadi A; Mohammadnejad F; Amini M; Mokhtazadeh A; Asadzadeh Z; Chi-Shing Cho W; Baradaran B
Adv Pharm Bull; 2023 Jul; 13(3):551-562. PubMed ID: 37646068
[TBL] [Abstract][Full Text] [Related]
4. Multi-omics sequencing revealed endostar combined with cisplatin treated non small cell lung cancer via anti-angiogenesis.
Wang Y; Ren H
BMC Cancer; 2024 Feb; 24(1):187. PubMed ID: 38331776
[TBL] [Abstract][Full Text] [Related]
5. Improvement of 5-fluorouracil chemosensitivity in colorectal cancer cells by siRNA-mediated silencing of STAT6 oncogene.
Rahbar Farzam O; Baradaran B; Akbari B; Najafi S; Amini M; Yari A; Dabbaghipour R; Pourabdollah Kaleybar V; Ahdi Khosroshahi S
Iran J Basic Med Sci; 2024; 27(4):475-484. PubMed ID: 38419894
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of the nanoscale lysate derived from xenogenic dental pulp stem cells in lung cancer models.
He Y; Li R; She W; Ai Y; Li K; Kumeria T; Jiang Z; Shao Q; Zou C; Albashari AA; Duan X; Ye Q
J Nanobiotechnology; 2023 Dec; 21(1):488. PubMed ID: 38105218
[TBL] [Abstract][Full Text] [Related]
7. TonEBP/NFAT5 expression is associated with cisplatin resistance and migration in macrophage-induced A549 cells.
Song HJ; Kim YH; Choi HN; Kim T; Kim SJ; Kang MW; Lee SD
BMC Mol Cell Biol; 2024 Mar; 25(1):6. PubMed ID: 38438872
[TBL] [Abstract][Full Text] [Related]
8. CRTAC1 enhances the chemosensitivity of non-small cell lung cancer to cisplatin by eliciting RyR-mediated calcium release and inhibiting Akt1 expression.
Jin Z; Zhao L; Chang Y; Jin R; Hu F; Wu S; Xue Z; Ma Y; Chen C; Zheng M; Chang Y; Jin H; Xie Q; Huang C; Huang H
Cell Death Dis; 2023 Aug; 14(8):563. PubMed ID: 37633993
[TBL] [Abstract][Full Text] [Related]
9. Investigation the effects of bee venom and H-dental-derived mesenchymal stem cells on non-small cell lung cancer cells (A549).
Sengul F; Vatansev H; Ozturk B
Mol Biol Rep; 2023 Dec; 51(1):2. PubMed ID: 38057592
[TBL] [Abstract][Full Text] [Related]
10. Investigating the effect of LncRNA DLGAP1-AS2 suppression on chemosensitivity of gastric cancer to chemotherapy.
Azadi SS; Safaralizadeh R; Amini M; Hosseinpour Feizi MA; Abdolzadeh S; Najafi S; Bahojb Mahdavi SZ; Yari A; Narimanzadeh L; Baradaran B; Mokhtarzadeh AA
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; ():. PubMed ID: 38748228
[TBL] [Abstract][Full Text] [Related]
11. MiR-145 inhibits cell migration and increases paclitaxel chemosensitivity in prostate cancer cells.
Tohidast M; Memari N; Amini M; Hosseini SS; Jebelli A; Doustvandi MA; Baradaran B; Mokhtarzadeh A
Iran J Basic Med Sci; 2023; 26(11):1350-1359. PubMed ID: 37886001
[TBL] [Abstract][Full Text] [Related]
12. NRF2 Suppression Enhances the Susceptibility of Pancreatic Cancer Cells, Miapaca-2 to Paclitaxel.
Riazi-Tabrizi N; Khalaj-Kondori M; Safaei S; Amini M; Hassanian H; Maghsoudi M; Hasani S; Baradaran B
Mol Biotechnol; 2023 Sep; ():. PubMed ID: 37740817
[TBL] [Abstract][Full Text] [Related]
13. siRNA-mediated knockdown of ID1 disrupts Nanog- and Oct-4-mediated cancer stem cell-likeness and resistance to chemotherapy in gastric cancer cells.
Li L; Wei X; Wu B; Xiao Y; Yin M; Yang Q
Oncol Lett; 2017 May; 13(5):3014-3024. PubMed ID: 28529558
[TBL] [Abstract][Full Text] [Related]
14. Cooperative Treatment of Gastric Cancer Using B7-H7 siRNA and Docetaxel; How Could They Modify Their Effectiveness?
Bolandi N; Khadem Ansari MH; Rasmi Y; Baradaran B
Adv Pharm Bull; 2023 Jul; 13(3):573-582. PubMed ID: 37646055
[TBL] [Abstract][Full Text] [Related]
15. The Redox-Active Manganese(III) Porphyrin, MnTnBuOE-2-PyP
Soares RB; Manguinhas R; Costa JG; Saraiva N; Gil N; Rosell R; Camões SP; Batinic-Haberle I; Spasojevic I; Castro M; Miranda JP; Guedes de Pinho P; Fernandes AS; Oliveira NG
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568630
[TBL] [Abstract][Full Text] [Related]
16. Combined treatment with acetazolamide and cisplatin enhances chemosensitivity in laryngeal carcinoma Hep-2 cells.
Gao H; Dong H; Li G; Jin H
Oncol Lett; 2018 Jun; 15(6):9299-9306. PubMed ID: 29928333
[TBL] [Abstract][Full Text] [Related]
17. Antihyperlipidemic drug rosuvastatin suppressed tumor progression and potentiated chemosensitivity by downregulating CCNA2 in lung adenocarcinoma.
Tan XD; Luo CF; Liang SY
J Chemother; 2024 Jan; ():1-13. PubMed ID: 38288951
[TBL] [Abstract][Full Text] [Related]
18. Erianin suppressed lung cancer stemness and chemotherapeutic sensitivity via triggering ferroptosis.
Lv J; Wang Z; Liu H
Environ Toxicol; 2024 Feb; 39(2):479-486. PubMed ID: 37209271
[TBL] [Abstract][Full Text] [Related]
19. Menadione : sodium orthovanadate combination eliminates and inhibits migration of detached cancer cells.
Delwar ZM; Siden A; Cruz MH; Yakisich JS
ISRN Pharmacol; 2012; 2012():307102. PubMed ID: 22957270
[TBL] [Abstract][Full Text] [Related]
20. Expression of concern: miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1 [Biomedicine & Pharmacotherapy 106 (2018) 1072-1081].
Biomed Pharmacother; 2022 Nov; 155():113813. PubMed ID: 36271518
[No Abstract] [Full Text] [Related]
[Next] [New Search]
